The use of natriuretic peptides in the intensive care unit

Current Opinion in Critical Care

Volumn 14, Issue 5, 2008, Pages 536-542

  Pirracchio, Romain ^a   Logeart, Damien ^a   Noveanu, Markus ^b   Mebazaa, Alexandre ^a   Mueller, Christian ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Diagnosis; Heart failure; ICU; Natriuretic peptides; Prognosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ARTIFICIAL VENTILATION; CARDIOGENIC SHOCK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CRITICALLY ILL PATIENT; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DISEASE MARKER; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FUNCTION; HEMODYNAMIC PARAMETERS; HUMAN; INTENSIVE CARE UNIT; LUNG EDEMA; LUNG EMBOLISM; MYOCARDIAL DISEASE; PERIOPERATIVE COMPLICATION; PILOT STUDY; POSITIVE END EXPIRATORY PRESSURE; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY FAILURE; REVIEW; SCREENING; SEPSIS; VALVULAR HEART DISEASE;

BIOLOGICAL MARKERS; HEART FAILURE; HUMANS; INTENSIVE CARE UNITS; NATRIURETIC PEPTIDE, BRAIN;

EID: 55349135937     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e32830c4875     Document Type: Review

References (39)

1. Mueller C, Breidthardt T, Laule-Kilian K, et al. The integration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly 2007; 137:4-12. Comprehensive summary of the clinical utility of BNP and NT-proBNP.
2. Iwanaga Y, Nishi I, Furuichi S, et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006; 47: 742-748.
3. Jefic D, Lee JW, Jefic D, et al. Utility of B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide in evaluation of respiratory failure in critically ill patients. Chest 2005; 128:288-295.
4. Bal L, Thierry S, Brocas E, et al. B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress. Acta Anaesthesiol Scand 2006; 50:340-347.
5. Forfia PR, Watkins SP, Rame JE, et al. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. J Am Coll Cardiol 2005; 45:1667-1671.
6. Karmpaliotis D, Kirtane AJ, Ruisi CP, et al. Diagnostic and prognostic utility of brain natriuretic peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema. Chest 2007; 131:964-971. Using a dedicated gold standard diagnosis, this study quantifies the accuracy of BNP to detect cardiogenic pulmonary edema.
7. Thierry S, Lecuyer L, Brocas E, et al. Interest of the brain natriuretic peptide as a marker of acute cor pulmonale in acute respiratory distress syndrome. Ann Fr Anesth Reanim 2006; 25:815-819.
8. Bando M, Ishii Y, Sugiyama Y, Kitamura S. Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale. Respir Med 1999; 93:507-514.
9. Nakanishi K, Tajima F, Itoh H, et al. Changes in atrial natriuretic peptide and brain natriuretic peptide associated with hypobaric hypoxia-induced pulmonary hypertension in rats. Virchows Arch 2001; 439:808-817.
10. Abroug F, Ouanes-Besbes L, Nciri N, et al. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers. Am J Respir Crit Care Med 2006; 174:990-996.
11. Januzzi JL Jr, Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005; 95:948-954.
12. Tung RH, Garcia C, Morss AM, et al. Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 2004; 32:1643-1647.
13. Januzzi JL, Morss A, Tung R, et al. Natriuretic peptide testing for the evaluation of critically ill patients with shock in the Intensive care unit: a prospective cohort study. Crit Care 2006; 10:R37.
14. Rudiger A, Gasser S, Fischler M, et al. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med 2006;34:2140-2144.
15. Mekontso-Dessap A, Tual L, Kirsch M, et al. B-type natriuretic peptide to assess haemodynamic status after cardiac surgery. Br J Anaesth 2006; 97:777-782.
16. Johnson W, Omland T, Hall C, et al. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol 2002; 39:1623-1629.
17. Logeart D, Lecuyer L, Thabut G, et al. Biomarker-based strategy for screening right ventricular dysfunction in patients with nonmassive pulmonary embolism. Intensive Care Med 2007; 33:286-292. BNP accurately detects right ventricular dysfunction by echocardiography.
18. Pieralli F, Olivotto I, Vanni S, et al. Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism. Am J Cardiol 2006; 97:1386-1390.
19. Kruger S, Graf J, Merx MW, et al. Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. Am Heart J 2004; 147:60-65.
20. Mekontso-Dessap A, de Prost N, Girou E, et al. B-type natriuretic peptide and weaning from mechanical ventilation. Intensive Care Med 2006; 32:1529-1536.
21. Ait-Oufella H, Tharaux PL, Baudel JL, et al. Variation in natriuretic peptides and mitral flow indexes during successful ventilatory weaning: a preliminary study. Intensive Care Med 2007; 33:1183-1186.
22. Witthaut R, Busch C, Fraunberger P, et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 2003; 29:1696-1702.
23. Nikolaou NI, Goritsas C, Dede M, et al. Brain natriuretic peptide increases in septic patients without severe sepsis or shock. Eur J Intern Med 2007; 18:535-541.
24. Charpentier J, Luyt CE, Fulla Y, et al. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004; 32:660-665.
25. Roch A, Allardet-Setvent J, Michelet P, et al. NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med 2005; 33:1001-1007.
26. Shor R, Rozenman Y, Bolshinsky A, et al. BNP in septic patients without systolic myocardial dysfunction. Eur J Intern Med 2006; 17:536-540.
27. McLean AS, Huang SJ, Hyams S, et al. Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock. Crit Care Med 2007; 35:1019-1026.
28. Tanaka T, Kanda T, Takahashi T, et al. Interleukin-6-induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes. J Int Med Res 2004; 32:57-61.
29. Ma KK, Ogawa T, de Bold AJ. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 2004; 36:505-513.
30. He Q, LaPointe MC. Interleukin-1 beta regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes. Hypertension 1999; 33 (1 Pt 2):283-289.
31. McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998; 351:9-13.
32. McLean AS, Tang B, Nalos M, et al. Increased B-type natriuretic peptide (BNP) level is a strong predictor for cardiac dysfunction in intensive care unit patients. Anaesth Intensive Care 2003; 31:21-27.
33. Kucher N, Goldhaber SZ. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation 2003; 108:2191-2194.
34. Grabowski M, Filipiak KJ, Malek LA, et al. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty. Int J Cardiol 2007; 115:386-390.
35. Shah KB, Nolan MM, Rao K, et al. The characteristics and prognostic importance of NT-ProBNP concentrations in critically ill patients. Am J Med 2007; 120:1071-1077.
36. Hutfless R, Kazanegra R, Madani M, et al. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 2004; 43:1873-1879.
37. Phua J, Lim TK, Lee KH. B-type natriuretic peptide: issues for the intensivist and pulmonologist. Crit Care Med 2005; 33:2094-2113.
38. Pirracchio R, Deye N, Lukaszewicz AC, et al. Impaired plasma B-type natriuretic peptide (BNP) clearance in human septic shock. Crit Care Med (in press).
39. Morgenthaler NG, Struck J, Christ-Crain M, et al. Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Crit Care 2005; 9:R37-R45.